Bubs Australia Won Permanent US Access — Then Its Shares Jumped 45%
The FDA authorised three infant-formula products for permanent US marketing, replacing emergency-era uncertainty and opening a path to branded and private-label expansion.
8 Sep 2026, 1:21 AM IST